Subscribe

Main navigation

Home
Conferences
2026 Washington, DC
2026 London
2025 Berlin
2024 Athens
2023 New York City
CME
Spotlight
Studies
Media
About
About SEGM
FAQ
Our Response to the SPLC
Contact
Grant Opportunities
Support

Search results

Rethinking Youth Gender Medicine

Conferences
This November 5-7 in Washington DC, we’ll bring together researchers, clinicians, and people whose lives have been touched by gender medicine to talk about the evidence, ethics, and a path forward for children and young people experiencing gender-related distress.
Matched fragments:
… gender dysphoric youth with puberty blockers and cross-sex hormones. … Her review of the impact of puberty blockers on neurodevelopment …

6. Managing Gender Dysphoria in Youth: European Practice Changes

September 11, 2025
CME | Course

Over the past decade, Europe has undergone a paradigm shift in the care of gender-dysphoric youth. In December 2024, the UK indefinitely banned puberty blockers for gender dysphoria outside research trials, while Sweden, Finland, and Norway implemented significant restrictions between 2020 and...

Matched fragments:
… 2024, the UK indefinitely banned puberty blockers for gender dysphoria … low-certainty findings for puberty suppression, detransition …

Our Response to the Southern Poverty Law Center

September 5, 2025
Other

September 10, 2025

The Society for Evidence-Based Gender Medicine was established to promote evidence-based, ethical care for children, adolescents, and young adults with gender dysphoria. In recent years, politicized attacks on organizations and individual researchers working in this...

Matched fragments:
… reviews—into the use of puberty blockers , cross-sex hormones , and … for an end to prescription puberty blockers for trans kids”  is …

Reassessing the Trevor Project’s Suicide-Attempt Findings

June 16, 2026
Spotlight
A peer-reviewed critique challenges the Trevor Project’s claim that anti-trans laws caused up to a 72% increase in youth suicide attempts, highlighting Idaho’s central role.
Matched fragments:
… healthcare (for example, puberty blockers, hormone therapy and … in the UK that the country’s puberty-blocker ban caused a surge …

Gender Identity 5 Years After Social Transition

May 4, 2022
Studies

SEGM Summary:This study examined the 5-year gender identity development trajectory of transgender-identified children who underwent early social gender transition (SGT). The children were, on average, 6-7 years old at the time of SGT. Five years later, at the average age of 11-12, almost all—97....

Matched fragments:
… initiated interventions with puberty blockers (29%) and cross-sex …

A Legal Assessment of the Dutch Protocol for Transgender Care to Children: Evidence, Ethics and Procedure

April 1, 2025
Studies

In this article, two Dutch legal experts (Smeehuijzen and Hoekstra) and a medical ethicist (Smids) evaluate whether the Dutch Protocol as laid out in the 2018 Dutch guideline for somatic gender care (i.e., medical and surgical interventions) meets the necessary requirements for it to have...

Matched fragments:
… by reducing lower age limits for puberty blockers, cross-sex hormones, and …

Factors Associated With Desistence and Persistence of Childhood Gender Dysphoria: A Quantitative Follow-Up Study

June 1, 2013
Studies

SEGM Summary

Among other findings, young boys who are socially transitioned are at vastly greater risk of persisting into a regime of puberty blockers and cross-sex hormones.

Matched fragments:
… of persisting into a regime of puberty blockers and cross-sex hormones. …

Individuals Treated for Gender Dysphoria with Medical and/or Surgical Transition Who Subsequently Detransitioned: A Survey of 100 Detransitioners

November 1, 2021
Studies

To qualify as medically or surgically transitioned, participants needed to have had one or more of the following interventions for the purpose of transitioning: puberty blockers, cross-sex hormones, anti-androgens, or a surgical procedure, and then detransitioned by stopping the medications or...

Matched fragments:
… for the purpose of transitioning: puberty blockers, cross-sex hormones, … dysphoria (56%) vs. the post-puberty onset (44.0%). However, more …

Gender detransition: a case study

September 1, 2021
Studies

What happens when a young person's intensely experienced desire to undergo medical transition is granted, with minimal attention paid to the factors contributing to the development of gender dysphoria, and with no attempts to ameliorate the distress non-invasively first? This case study is an...

Matched fragments:
… of adolescents with post-puberty onset of gender dysphoria. … for GD. Under this model of care, puberty blockers are provided to children at …

Promotion and protection of all human rights, civil, political, economic, social and cultural rights, including the right to development

June 16, 2025
Studies

Last May, the United Nations published the report “A/HRC/59/47: Sex-based violence against women and girls: new frontiers and emerging issues”, authored by Reem Alsalem, Special Rapporteur on violence against women and girls, to be delivered at the 59th session of the Human Rights Council.

...
Matched fragments:
… and restrict children’s access to puberty blockers, cross-sex hormones and …

Pagination

  • First page « First
  • Previous page ‹
  • …
  • Page 10
  • Page 11
  • Current page 12
  • Page 13
  • Page 14
  • Next page ›
  • Last page Last »

SEGM is committed to safeguarding scientific integrity through open discourse and collaboration. Researchers and clinicians worldwide must be free to pursue scientific inquiry without censorship or intimidation.

Our Response to the SPLC
FAQs about SEGM
Close

Society for Evidence-Based Gender Medicine

© 2020-2026 SEGM